190 related articles for article (PubMed ID: 9890001)
1. RET proto-oncogene: role in kidney development and molecular pathology.
Salomon R; Attie T; Amiel J; Pelet A; Niaudet P; Lyonnet S
Adv Nephrol Necker Hosp; 1998; 28():401-17. PubMed ID: 9890001
[No Abstract] [Full Text] [Related]
2. Japanese patients with sporadic Hirschsprung: mutation analysis of the receptor tyrosine kinase proto-oncogene, endothelin-B receptor, endothelin-3, glial cell line-derived neurotrophic factor and neurturin genes: a comparison with similar studies.
Sakai T; Nirasawa Y; Itoh Y; Wakizaka A
Eur J Pediatr; 2000 Mar; 159(3):160-7. PubMed ID: 10664228
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of the development of human disease caused by RET mutations.
Romeo G
Jpn J Cancer Res; 1997 Jan; 88(1):Inside front cover. PubMed ID: 9045887
[No Abstract] [Full Text] [Related]
4. Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease.
Carlomagno F; Melillo RM; Visconti R; Salvatore G; De Vita G; Lupoli G; Yu Y; Jing S; Vecchio G; Fusco A; Santoro M
Endocrinology; 1998 Aug; 139(8):3613-9. PubMed ID: 9681515
[TBL] [Abstract][Full Text] [Related]
5. [Molecular basis of Hirschsprung disease].
Inoue M; Okada A
Nihon Rinsho; 1998 Jan; 56(1):249-57. PubMed ID: 9465697
[TBL] [Abstract][Full Text] [Related]
6. Germline mutations in glial cell line-derived neurotrophic factor (GDNF) and RET in a Hirschsprung disease patient.
Angrist M; Bolk S; Halushka M; Lapchak PA; Chakravarti A
Nat Genet; 1996 Nov; 14(3):341-4. PubMed ID: 8896568
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of the ret and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease.
Borrego S; Eng C; Sánchez B; Sáez ME; Navarro E; Antiñolo G
J Clin Endocrinol Metab; 1998 Sep; 83(9):3361-4. PubMed ID: 9745455
[TBL] [Abstract][Full Text] [Related]
8. Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors.
Marsh DJ; Zheng Z; Arnold A; Andrew SD; Learoyd D; Frilling A; Komminoth P; Neumann HP; Ponder BA; Rollins BJ; Shapiro GI; Robinson BG; Mulligan LM; Eng C
J Clin Endocrinol Metab; 1997 Sep; 82(9):3025-8. PubMed ID: 9284737
[TBL] [Abstract][Full Text] [Related]
9. Congenital central hypoventilation syndrome: a novel mutation of the RET gene in an isolated case.
Kanai M; Numakura C; Sasaki A; Shirahata E; Akaba K; Hashimoto M; Hasegawa H; Shirasawa S; Hayasaka K
Tohoku J Exp Med; 2002 Apr; 196(4):241-6. PubMed ID: 12086152
[TBL] [Abstract][Full Text] [Related]
10. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes and Hirschsprung disease.
Smith DP; Eng C; Ponder BA
J Cell Sci Suppl; 1994; 18():43-9. PubMed ID: 7883791
[TBL] [Abstract][Full Text] [Related]
11. The GDNF-RET signalling partnership.
Robertson K; Mason I
Trends Genet; 1997 Jan; 13(1):1-3. PubMed ID: 9009838
[No Abstract] [Full Text] [Related]
12. Co-segregation of MEN2 and Hirschsprung's disease: the same mutation of RET with both gain and loss-of-function?
Takahashi M; Iwashita T; Santoro M; Lyonnet S; Lenoir GM; Billaud M
Hum Mutat; 1999; 13(4):331-6. PubMed ID: 10220148
[TBL] [Abstract][Full Text] [Related]
13. Genetic aspects of Hirschsprung's disease.
Kusafuka T; Puri P
Semin Pediatr Surg; 1998 Aug; 7(3):148-55. PubMed ID: 9718652
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of development of multiple endocrine neoplasia type 2 and Hirschsprung's disease by ret mutations.
Takahashi M; Asai N; Iwashita T; Murakami H; Ito S
Recent Results Cancer Res; 1998; 154():229-36. PubMed ID: 10027003
[TBL] [Abstract][Full Text] [Related]
15. Genetic basis of endocrine disease: multiple endocrine neoplasia type 2.
Mulligan LM; Ponder BA
J Clin Endocrinol Metab; 1995 Jul; 80(7):1989-95. PubMed ID: 7608246
[No Abstract] [Full Text] [Related]
16. Genetic analysis of RET, GFR alpha 1 and GDNF genes in Spanish families with multiple endocrine neoplasia type 2A.
Gil L; Azañedo M; Pollán M; Cristobal E; Arribas B; García-Albert L; García-Sáiz A; Maestro ML; Torres A; Menárguez J; Rojas JM
Int J Cancer; 2002 May; 99(2):299-304. PubMed ID: 11979448
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic variation in a family with mutations in two Hirschsprung-related genes (RET and endothelin receptor B).
Svensson PJ; Anvret M; Molander ML; Nordenskjöld A
Hum Genet; 1998 Aug; 103(2):145-8. PubMed ID: 9760196
[TBL] [Abstract][Full Text] [Related]
18. RET in human development and oncogenesis.
Edery P; Eng C; Munnich A; Lyonnet S
Bioessays; 1997 May; 19(5):389-95. PubMed ID: 9174404
[TBL] [Abstract][Full Text] [Related]
19. The RET receptor: function in development and dysfunction in congenital malformation.
Manié S; Santoro M; Fusco A; Billaud M
Trends Genet; 2001 Oct; 17(10):580-9. PubMed ID: 11585664
[TBL] [Abstract][Full Text] [Related]
20. RET mutations in multiple endocrine neoplasia type 2 and Hirschsprung disease.
Reynolds LF; Eng C
Curr Opin Pediatr; 1995 Dec; 7(6):702-9. PubMed ID: 8776023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
